Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 440
Summary
- Conditions
- Alzheimer's Disease
- Type
- Observational
- Design
- Observational Model: Case-CrossoverTime Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 45 years and 75 years
- Gender
- Both males and females
Description
18F-Flutemetamol scans will be categorized as either positive or negative according to the standardized uptake value ratio (a quantitative measurement based on a ratio of mean target cortex activity divided by that in a cerebellar reference region). Participants with a SUVr over 1.56 will be classif...
18F-Flutemetamol scans will be categorized as either positive or negative according to the standardized uptake value ratio (a quantitative measurement based on a ratio of mean target cortex activity divided by that in a cerebellar reference region). Participants with a SUVr over 1.56 will be classified as positive and, otherwise, as negative.
Tracking Information
- NCT #
- NCT02685969
- Collaborators
- Hospital Clinic of Barcelona
- General Electric
- Investigators
- Principal Investigator: Jose Luis Molinuevo, MD, PhD Scientific Director